Silicone implant surface microtopography modulates inflammation and tissue repair in capsular fibrosis

Front Immunol. 2024 Mar 19:15:1342895. doi: 10.3389/fimmu.2024.1342895. eCollection 2024.

Abstract

Excessive fibrous capsule formation around silicone mammary implants (SMI) involves immune reactions to silicone. Capsular fibrosis, a common SMI complication linked to host responses, worsens with specific implant topographies. Our study with 10 patients investigated intra- and inter-individually, reduced surface roughness effects on disease progression, wound responses, chronic inflammation, and capsular composition. The results illuminate the significant impact of surface roughness on acute inflammatory responses, fibrinogen accumulation, and the subsequent fibrotic cascade. The reduction of surface roughness to an average roughness of 4 μm emerges as a promising approach for mitigating detrimental immune reactions, promoting healthy wound healing, and curbing excessive fibrosis. The identified proteins adhering to rougher surfaces shed light on potential mediators of pro-inflammatory and pro-fibrotic processes, further emphasizing the need for meticulous consideration of surface design. The composition of the implant capsule and the discovery of intracapsular HSP60 expression highlight the intricate web of stress responses and immune activation that can impact long-term tissue outcomes.

Keywords: FBR (foreign body response); HSP60-mediated T-cell activation; SMI (silicone mammary implants); SMI surface protein adsorption; immunomics; implant encapsulation; implant surface topography; pro-inflammatory mechanical stress mechanisms.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Fibrosis
  • Humans
  • Inflammation*
  • Prostheses and Implants*
  • Silicones
  • Wound Healing

Substances

  • Silicones

Grants and funding

The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. Research on this project was funded by Establishment Labs, Costa Rica (ID D152500-015-015) to DW.